comprehensive -WSS

comprehensive

author：knowledge 2025-09-04 05:34:35 - browse：31742

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

explore

focus

WSS

Food makers tried to stack nutrition panel with preferred experts

What to make of Biden’s latest efforts on cancer research

Questions and answers about ramping up H5N1 bird flu vaccine

Private equity could exacerbate cardiology's overuse problem, experts fear

Regeneron agrees to White House price limits on anti

PEPFAR is under serious threat — and so is global health

entertainment

comprehensive

Wikipedia

Affirmative action in medical school literally saved lives

Bird flu surveillance in wastewater gets boost from consortium

Moonlake's readout produced a cash windfall. Risks remain

Citing H5N1 threat, CDC urges peak flu monitoring this summer

23andMe had bad news about my health. I wish a person had delivered it

Investigation reveals sickle cell patients pressured into sterilizations

FDA approval of Sarepta Duchenne genetic therapy gives me hope

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Hollywood unions extend contract negotiations for actors

H5N1 bird flu outbreak: Second human case reported, in Michigan

knowledge

White House touts steps to stem shortages of cancer treatments

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Study finds gene variants tied to breast cancer risk in Black women

As a primary care physician, here's how I hope to partner with AI

Private equity could exacerbate cardiology's overuse problem, experts fear

At flashy new research hub, AstraZeneca lays out ambitious growth goals

explore

leisure time

focus

explore